Home RxNorm 1726102 bendamustine hydrochloride 25 MG/ML Injectable Solution [Bendeka] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1726102
RxNorm name bendamustine hydrochloride 25 MG/ML Injectable Solution [Bendeka]
Display name BENDEKA (Injectable)
Full name bendamustine hydrochloride 25 MG/ML Injectable Solution [Bendeka]
Term type SBD
Status Active
Strength 25 mg/ml
Dose form Sol
Route Injectable
Updated 2026-10-21 00:30:46 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 012016
Active start 012016
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength bendamustine hydrochloride 25 MG / 1 ML bendamustine bendamustine hydrochloride
Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 63459-348-04 63459-348 Bendeka bendamustine hydrochloride Teva Pharmaceuticals USA, Inc. NDA208194
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler NDA208194 63459-348 Bendeka bendamustine hydrochloride NDA Teva Pharmaceuticals USA, Inc.
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.
NDC11, Source, Active table NDC11 Source Active 63459034804 rxnav_ndcs yes
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective ace9a43b-f9bd-4896-abfe-0ef4fec67ddf BENDEKA 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [Bendeka] [SBD] · Bendeka 25 MG/ML Injectable Solution [SY] 3 22 These highlights do not include all the information needed to use BENDEKA safely and effectively. See full prescribing information for BENDEKA. BENDEKA ® (bendamustine hydrochloride injection), for intravenous use Initial U.S. Approval: 2008 20240119
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective ace9a43b-f9bd-4896-abfe-0ef4fec67ddf These highlights do not include all the information needed to use BENDEKA safely and effectively. See full prescribing information for BENDEKA. BENDEKA ® (bendamustine hydrochloride injection), for intravenous use Initial U.S. Approval: 2008 Teva Pharmaceuticals USA, Inc. 20240119
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 25 MG/ML (expressed as bendamustine hydrochloride) ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES NDA NDA208194 NAMES Prescribable Synonym BENDEKA 25 MG/ML Injectable Solution SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon